| Ms Nicolene Engelbrecht, RPH | |
|
2080 Nw 9th Street, Corvallis, OR 97330 | |
| (541) 753-2226 | |
| Not Available |
| Full Name | Ms Nicolene Engelbrecht |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2080 Nw 9th Street, Corvallis, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043503709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 03230721 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nicolene Engelbrecht, RPH 2080 Nw 9th Street, Rite Aid Pharmacy, Corvallis, OR 97330 Ph: (541) 753-2226 | Ms Nicolene Engelbrecht, RPH 2080 Nw 9th Street, Corvallis, OR 97330 Ph: (541) 753-2226 |
News Archive
Singapore International Water Week today announced that Dr James L. Barnard has been awarded the Lee Kuan Yew Water Prize 2011, a prestigious award that recognises outstanding contributions towards solving global water problems by either applying technologies or implementing policies and programmes which benefit humanity.
Jersey Shore University Medical Center recently unveiled the new CardioVascular Intensive Care Unit (CVICU) - a twelve bed critical care unit providing post-operative care for cardiac surgery patients, including those who receive traditional open heart surgery and newer, complex interventional cardiovascular procedures.
A new cause of obesity due to a defect on chromosome 16 has just been discovered. It is thought to explain close to 1% of obesity cases. For carriers of the defect, the risk of becoming overweight is 50 times higher. This research is the result of close cooperation between the team of Professor Froguel, a CNRS researcher, in Lille, and colleagues at Imperial College in London and Vaudois University Hospital in Lausanne, with the support of ten other European research groups. The findings of the study are to be published in Nature on February 4, 2010.
AstraZeneca today announced new analyses of exenatide once weekly (ExQW) demonstrating a favorable gastrointestinal (GI) tolerability profile, including less frequent upper and lower GI adverse events (AE), compared to shorter-acting glucagon-like peptide-1 receptor agonists (GLP-1RA), exenatide twice daily (ExBID) and liraglutide once daily (LiraQD).
› Verified 2 days ago
Dr. Melissa Marie Elliott, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 501 Nw Elks Dr Ste 100, Corvallis, OR 97330 Phone: 541-768-5495 | |
Mr. Marshall R. Thompson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 777 Nw Kings Blvd, Corvallis, OR 97330 Phone: 541-754-5583 Fax: 541-754-5577 | |
Aaron Nichols, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3521 Nw Samaritan Dr Ste 202, Corvallis, OR 97330 Phone: 541-768-1299 | |
Linda M Samuels, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 109 Plageman Bldg, Osu Pharmacy, Corvallis, OR 97331 Phone: 541-737-3491 Fax: 541-737-7616 | |
Mr. Thomas Michael Field, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 910 Nw Kings Blvd, Corvallis, OR 97330 Phone: 541-752-7779 Fax: 541-752-8659 | |
Divyalben Y Patel, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1126 Ne Conser Pl, Corvallis, OR 97330 Phone: 150-390-1400 Fax: 503-901-4009 |